AI joins radiologists in massive liver tumor diagnosis trial
NCT ID NCT07153783
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This large completed trial tested whether an AI system can help radiologists better diagnose liver tumors from CT scans. Over 10,000 adults with various liver conditions participated. The AI analyzed scans overnight, and a senior radiologist reviewed any differences between the AI and the initial report. The goal was to see if this teamwork improves diagnostic accuracy in real-world hospital settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-human collaborative diagnostic system for contrast-enhanced CT scans
What this could lead to
If successful, this could show that AI helps radiologists diagnose liver tumors more accurately and efficiently in real-world settings.
What could go wrong
This is a completed trial, but results are not yet published. The AI may not perform as well in practice as in earlier studies, and it may not work for all types of liver lesions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004, China